Quest Diagnostics provides long-term outlook: 4-5% revenue CAGR; reaffirms FY2025 guidance but notes Q1 weather headwind

QUEST DIAGNOSTICS INC

Long-term outlook: revenue CAGR 4-5%, adjusted EPS CAGR 7-9% beyond 2025.
Reaffirms FY2025 guidance: revenue $10.70B-$10.85B, adjusted EPS $9.55-$9.80.
Q1 2025 weather headwind of ~$25M revenue and ~$0.10 EPS expected.
Strategic initiatives include Invigorate productivity (3% annual savings) and Project Nova IT modernization.
Double-digit growth targeted in advanced diagnostics: oncology, cardiometabolic, brain health, others.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.